.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Deloitte
Fuji
Accenture
Harvard Business School
Baxter
Teva
Cerilliant
Cantor Fitzgerald
Medtronic

Generated: September 26, 2017

DrugPatentWatch Database Preview

SCANLUX-300 Drug Profile

« Back to Dashboard

Which patents cover Scanlux-300, and when can generic versions of Scanlux-300 launch?

Scanlux-300 is a drug marketed by Sanochemia Corp Usa and is included in one NDA.

The generic ingredient in SCANLUX-300 is iopamidol. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the iopamidol profile page.

Summary for Tradename: SCANLUX-300

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list26
Clinical Trials: see list2,252
Patent Applications: see list1,590
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SCANLUX-300 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanochemia Corp Usa
SCANLUX-300
iopamidol
INJECTABLE;INJECTION090394-001Jun 18, 2010APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Covington
AstraZeneca
Johnson and Johnson
US Department of Justice
Merck
Deloitte
Moodys
Federal Trade Commission
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot